Taskin Eylem, Samper Natalie, Yang Hua-Qian, Nakamura Tomoe Y, Ramasamy Ravichandran, Coetzee William A
Department of Physiology, Adiyaman University, Adiyaman, Turkey.
Cyrus Tang Medical Institute, Soochow University, Suzhou, 215123, China.
Arh Farm (Belgr). 2024;74(5):625-657. doi: 10.5937/arhfarm74-51604. Epub 2024 Nov 1.
This review discusses ATP-sensitive potassium (K) channels, which connect intracellular energy metabolism to cellular electrical activity and play crucial roles in various physiological processes, particularly in the pancreas and cardiovascular system. K channels open when ATP levels decrease during metabolic stress, such as ischemia, helping to protect the heart from injury by maintaining membrane potential and preventing calcium overload. These channels are found in multiple cell types across the cardiovascular system, influencing vascular tone and cardiac excitability. The review highlights the need for further research into the specific expression of K channel subunits in humans and the consequences of ischemic events on their functionality. Additionally, it explores the interplay between glycolysis and K channels, suggesting that glycolytic ATP can modulate K channel activity while emphasizing the cardioprotective effects during ischemic events. The potential for K channel openers (KCOs) as therapeutic agents for ischemic heart disease is noted, particularly in improving outcomes in patients undergoing cardiac procedures. Challenges remain in developing specific KCOs with minimal side effects, but advances in precision medicine may enhance targeted therapies in the future. Overall, K channels represent promising targets for enhancing cardiovascular health.
本综述讨论了ATP敏感性钾(K)通道,该通道将细胞内能量代谢与细胞电活动联系起来,并在各种生理过程中发挥关键作用,尤其是在胰腺和心血管系统中。当在诸如局部缺血等代谢应激期间ATP水平降低时,K通道开放,通过维持膜电位和防止钙超载来帮助保护心脏免受损伤。这些通道存在于整个心血管系统的多种细胞类型中,影响血管张力和心脏兴奋性。该综述强调了进一步研究K通道亚基在人类中的具体表达以及缺血事件对其功能的影响的必要性。此外,它还探讨了糖酵解与K通道之间的相互作用,表明糖酵解产生的ATP可以调节K通道活性,同时强调了缺血事件期间的心脏保护作用。文中提到了K通道开放剂(KCOs)作为缺血性心脏病治疗药物的潜力,特别是在改善接受心脏手术患者的预后方面。在开发副作用最小的特异性KCOs方面仍然存在挑战,但精准医学的进展可能会在未来增强靶向治疗。总体而言,K通道是增强心血管健康的有前景的靶点。